| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080096901 Aminotriazole compounds useful as inhibitors of protein kinases |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096867 Imidazo[1,2-A] Pyridine Anxiolytics |
| 04/24/2008 | US20080096865 Improved photodynamic treatment against subfoveal choroidal neovascularization; administering midostaurin, vatalanib dihydrochloride or octreotide with a photosensitive porphyrin or purpurin; angiogenesis inhibition |
| 04/24/2008 | US20080096862 Lactam compounds and pharmaceutical use thereof |
| 04/24/2008 | US20080096859 Compositions and Methods for Treating Ophthalmic Diseases |
| 04/24/2008 | US20080096852 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 04/24/2008 | US20080096817 administering actin-sequestering peptides, for the treatment, prevention of injury or inflammation of eyes due to surgery or dryness |
| 04/24/2008 | US20080095804 Two-step immunization procedure against chlamydia infection |
| 04/24/2008 | US20080095754 Epithelium cell stabilizer component comprising diglycine, triglycine, tetraglycine and/or pentaglycine for use in treatment of dry eye |
| 04/24/2008 | US20080095753 Pharmacological vitreolysis |
| 04/24/2008 | US20080094573 Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof |
| 04/24/2008 | DE102006049091A1 Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl Emulsifier-free ophthalmic preparation containing vegetable oil |
| 04/24/2008 | CA2675500A1 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | CA2666841A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | CA2665376A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1912977A1 Ep4 receptor agonist, compositions and methods thereof |
| 04/23/2008 | EP1912957A1 Ep4 receptor agonist, compositions and methods thereof |
| 04/23/2008 | EP1912707A2 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166742A Novel lactam compound |
| 04/23/2008 | CN101164594A Paste suitable for fundus disease and retinal microcirculation disease and preparation method thereof |
| 04/23/2008 | CN101164579A Traditional Chinese medicine for curing keratitis |
| 04/23/2008 | CN101164542A Use of mometasone furoate for preparing drug |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100382837C A medicine for treating children's excessive blink, hyperkinetic syndrome and Tottre's syndrome and method for preparing same |
| 04/23/2008 | CN100382820C Chinese medicinal preparation for increasing memory and improving eyesight and method for preparing same |
| 04/23/2008 | CN100382797C Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7360504 Radiopaque animal chew |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2297082C Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/22/2008 | CA2280183C Method of treating dry eye disease with purinergic receptor agonists |
| 04/22/2008 | CA2279963C Dinucleotides and their use |
| 04/17/2008 | WO2008045663A2 Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents |
| 04/17/2008 | WO2008045186A1 Method of treatment of otitis externa |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044734A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | WO2008044733A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
| 04/17/2008 | WO2008043142A1 Method of treating hearing loss |
| 04/17/2008 | WO2008021933A3 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/17/2008 | WO2008020032A8 Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases |
| 04/17/2008 | WO2006127987A3 Treatment of eye disorders with sirtuin modulators |
| 04/17/2008 | US20080090914 Staining Composition For Staining An Ophthalmic Membrane |
| 04/17/2008 | US20080090896 Strontium-Based Treatment Of Otosclerosis |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090855 Substituted Cyclic Urea Derivatives and the Use Thereof as Vanilloid Receptor 1 Modulators |
| 04/17/2008 | US20080090841 pyrazinoylguanidine derivatives; more potent, more specific, and/or absorbed less rapidly from mucosal surfaces, and/or are less reversible, give a prolonged pharmacodynamic half-life; treating anthrax, chronic bronchitis, cystic fibrosis,chronic obstructive pulmonary disease, emphysema, pneumonia |
| 04/17/2008 | US20080090827 Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | US20080090751 Method of promoting healing of a tympanic membrane perforation |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080089923 Biodegradable ocular implants and methods for treating ocular conditions |
| 04/17/2008 | US20080089868 Retinal stem cell compositions and methods for preparing and using same |
| 04/17/2008 | CA2666440A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | CA2666058A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911746A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
| 04/16/2008 | EP1911471A1 Agent for visualizing vitreous body |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/16/2008 | EP1911447A1 Eye drop preparation comprising xanthan gum and terpenoid |
| 04/16/2008 | EP1910380A1 Oxazolopyridine derivatives as sirtuin modulators |
| 04/16/2008 | EP1910297A1 Isoquinoline compounds |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | EP1909812A2 Small compounds that correct protein misfolding and uses thereof |
| 04/16/2008 | EP1909796A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to alleviate eye disorders |
| 04/16/2008 | EP1909755A2 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 04/16/2008 | EP1361885B1 Use of gamma-gt inhibitors for the treatment of chronic degenerative diseases |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | CN101163486A Use of azithromycin for the production of a medicament for treatment of ocular infections |
| 04/16/2008 | CN101163474A Drug for curing corneal and conjunctival disease |
| 04/16/2008 | CN101163465A Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors |
| 04/16/2008 | CN101161275A A composition for preventing and controlling eye tunica conjunctiva bulbaris pigmentation and vision hypofunction as well as its purpose |
| 04/16/2008 | CN101161266A Composition for preventing and controlling eye vision function caducity as well as its purpose |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381461C Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381169C Composite collagen eye drops |
| 04/16/2008 | CN100381120C Fibrauretine powder for injection and its production process |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |